PRCT

PROCEPT BioRobotics Corporation

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Steven CohenPoint72
$29M1.1M shares
AddQ1 2026
$28M
$25.01
$26.46
Baillie GiffordInvestor
$24M973.5k shares
TrimQ1 2026
$7.6M
$25.01
$26.46
Ken GriffinCitadel Advisors
$-5.1M
ExitQ1 2026
$5.1M
--
$26.46
Paul Tudor Jones IITudor Investment
$2.7M109.5k shares
AddQ1 2026
$2.0M
$25.01
$26.46
Jim SimonsRenaissance Technologies
$2.9M116.2k shares
TrimQ1 2026
$790k
$25.01
$26.46
Baillie GiffordInvestor
$32M1M shares
ExitQ4 2025
$31M
$31.46
$26.46

News

globenewswire.comPROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approvalglobenewswire.comMay 28globenewswire.comAUA Guidelines Strengthen Recommendation for Aquablation® Therapyglobenewswire.comMay 14seekingalpha.comPROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.comMay 12globenewswire.comPROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & Juneglobenewswire.comApr 30seekingalpha.comPROCEPT BioRobotics Corporation (PRCT) Q1 2026 Earnings Call Transcriptseekingalpha.comApr 30